Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma

被引:7
|
作者
Zhou, Xueliang [1 ]
Dou, Mengmeng [2 ]
Liu, Zaoqu [1 ]
Jiao, Dechao [1 ]
Li, Zhaonan [1 ]
Chen, Jianjian [1 ]
Li, Jing [1 ]
Yao, Yuan [1 ]
Li, Lifeng [3 ]
Li, Yahua [1 ]
Han, Xinwei [1 ]
机构
[1] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
LONG NONCODING RNA; CANCER; MICRORNAS; IDENTIFICATION; PROLIFERATION; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; PATHWAYS;
D O I
10.1155/2021/5518908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatocellular carcinoma (HCC) remains an important cause of cancer death. The molecular mechanism of hepatocarcinogenesis and prognostic factors of HCC have not been completely uncovered. Methods. In this study, we screened out differentially expressed lncRNAs (DE lncRNAs), miRNAs (DE miRNAs), and mRNAs (DE mRNAs) by comparing the gene expression of HCC and normal tissue in The Cancer Genome Atlas (TCGA) database. DE mRNAs were used to perform Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then, the miRNA and lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a competitive endogenous RNA (ceRNA) network by weighted gene coexpression network analysis (WGCNA). Moreover, univariable Cox regression and Kaplan-Meier curve analyses of DE lncRNAs and DE mRNAs were conducted. Finally, the lasso-penalized Cox regression analysis and nomogram model were used to establish a new risk scoring system and predict the prognosis of patients with liver cancer. The expression of survival-related DE lncRNAs was verified by qRT-PCR. Results. A total of 1896 DEmRNAs, 330 DElncRNAs, and 76 DEmiRNAs were identified in HCC and normal tissue samples. Then, the turquoise miRNA and turquoise lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a ceRNA network by WGCNA. In this ceRNA network, there were 566 lncRNA-miRNA-mRNA regulatory pairs, including 30 upregulated lncRNAs, 16 downregulated miRNAs, and 75 upregulated mRNAs. Moreover, we screened out 19 lncRNAs and 14 hub mRNAs related to prognosis from this ceRNA network by univariable Cox regression and Kaplan-Meier curve analyses. Finally, a new risk scoring system was established by selecting the optimal risk lncRNAs from the 19 prognosis-related lncRNAs through lasso-penalized Cox regression analysis. In addition, we established a nomogram model consisting of independent prognostic factors to predict the survival rate of HCC patients. Finally, the correlation between the risk score and immune cell infiltration and gene set enrichment analysis were determined. Conclusions. In conclusion, the results may provide potential biomarkers or therapeutic targets for HCC and the establishment of the new risk scoring system and nomogram model provides the new perspective for predicting the prognosis of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Screening of prognosis-related Immune cells and prognostic predictors in Colorectal Cancer Patients
    Deng, Shuangshuang
    Zhu, Qiping
    Chen, Hongyan
    Xiao, Tianyu
    Zhu, Yinshen
    Gao, Jinli
    Li, Qing
    Gao, Yong
    BMC CANCER, 2023, 23 (01)
  • [42] Identification of a TRP channel-related risk model for predicting prognosis and therapeutic effects of patients with hepatocellular carcinoma
    Pang, Chong
    Xu, Zhe
    Han, Jilong
    Li, Fujun
    Zhu, Hongyan
    Zhang, Jiaqi
    Wang, Dong
    Xu, Xundi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (18) : 16811 - 16825
  • [43] Identification of a TRP channel-related risk model for predicting prognosis and therapeutic effects of patients with hepatocellular carcinoma
    Chong Pang
    Zhe Xu
    Jilong Han
    Fujun Li
    Hongyan Zhu
    Jiaqi Zhang
    Dong Wang
    Xundi Xu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16811 - 16825
  • [44] Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma
    Chen, Zi-An
    Tian, Hui
    Yao, Dong-Mei
    Zhang, Yuan
    Feng, Zhi-Jie
    Yang, Chuan-Jie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
    Junjie Kong
    Guangsheng Yu
    Wei Si
    Guangbing Li
    Jiawei Chai
    Yong Liu
    Jun Liu
    BMC Cancer, 22
  • [46] Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
    Kong, Junjie
    Yu, Guangsheng
    Si, Wei
    Li, Guangbing
    Chai, Jiawei
    Liu, Yong
    Liu, Jun
    BMC CANCER, 2022, 22 (01)
  • [47] Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
    Meng, Tongyu
    Wang, Qingfeng
    Yang, Yufeng
    Ren, Yanling
    Shi, Yan
    FRONTIERS IN GENETICS, 2022, 13
  • [48] A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients
    Fang, Shuang-Sang
    Guo, Jin-Cheng
    Zhang, Jian-Hua
    Liu, Jin-Na
    Hong, Shuai
    Yu, Bo
    Gao, Yuhan
    Hu, Su-Pei
    Liu, Hai-Zhong
    Sun, Liang
    Zhao, Yi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) : 3569 - 3578
  • [49] Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes
    Li, Yan-ke
    Yan, Li-rong
    Jiang, Li-yue
    Xu, Qian
    Wang, Ben-gang
    DISEASE MARKERS, 2022, 2022
  • [50] Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
    Zhang, Zhen
    Zeng, Xiangyang
    Wu, Yinghua
    Liu, Yang
    Zhang, Xi
    Song, Zewen
    FRONTIERS IN IMMUNOLOGY, 2022, 13